NY A01193

Authorizes optometrists to prescribe specific oral medications for eye disease treatment after completing certification requirements, including a 40-hour course (minimum 24 hours live instruction) and passing an examination.

Permits oral prescriptions limited to: six antibiotics (amoxicillin/clavulanate, cephalexin, azithromycin, sulfamethoxazole/trimethoprim, doxycycline, tetracycline); two antiglaucoma agents for acute pressure increases (maximum one 24-hour prescription); and two antiviral agents for herpes zoster (maximum one 7-day prescription).

Requires optometrists prescribing antiglaucoma or antiviral oral agents to immediately refer patients to a licensed physician and complete additional 18 hours of continuing education related to systemic disease per triennial period.

Exempts optometrists graduating from accredited optometry colleges after January 1, 2021 from the separate certification course requirement if they pass the National Board of Examiners in Optometry examination.

Establishes a $250 fee for oral therapeutic pharmaceutical agent certification and takes effect two years after enactment, with continuing education provisions effective January 1, 2022.